Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major. [electronic resource]
Producer: 20100309Description: 405-9 p. digitalISSN:- 1432-0584
- Adolescent
- Adult
- Benzoates -- therapeutic use
- Child
- Deferasirox
- Female
- Ferritins -- blood
- Heart Diseases -- complications
- Humans
- Iron -- metabolism
- Iron Chelating Agents -- therapeutic use
- Iron Overload -- complications
- Liver -- metabolism
- Magnetic Resonance Imaging
- Male
- Triazoles -- therapeutic use
- Young Adult
- beta-Thalassemia -- complications
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.